 Avid Bioservices NASDAQ:CDMO was upgraded by equities researchers at BidaskClub from a hold rating to a buy rating in a research report issued to clients and investors on Friday, BidAskClub reports. Several other brokerages have also recently commented on CDMO. Zacks Investment Research cut shares of Avid Bioservices from a buy rating to a hold ... 